CARDIOVASC DRUG THER - CARDIOVASCULAR DRUGS AND THERAPY
Publications
- 2021
Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Arnold, N. & Koenig, W., 06.2021, In: CARDIOVASC DRUG THER. 35, 3, p. 627-635 9 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
- 2020
Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies
Brunetti, N. D., Tricarico, L., Tilz, R. R., Heeger, C-H., De Gennaro, L., Correale, M., Ieva, R., Di Biase, M., Rillig, A., Metzner, A. & Santoro, F., 04.2020, In: CARDIOVASC DRUG THER. 34, 2, p. 209-214 6 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
- 2009
Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: The epidemiological evidence
Koenig, W. & Khuseyinova, N., 02.2009, In: CARDIOVASC DRUG THER. 23, 1, p. 85-92 8 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research